Showing results (641-650 of 672) with videos related to
Sort By:
Pageof 68
Journal of Medicinal Chemistry|October 13, 2006
Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-amino 5-aryl thiophenes as a new class of tubulin inhibitorsRomeo Romagnoli, Pier Giovanni Baraldi, Vincent Remusat, et al.Molecules (Basel, Switzerland)|October 18, 2014
Evaluation of the toxicity of 5-aryl-2-aminoimidazole-based biofilm inhibitors against eukaryotic cell lines, bone cells and the nematode Caenorhabditis elegansHans Steenackers, Akanksha Dubey, Stijn Robijns, et al.Journal of Medicinal Chemistry|September 3, 2010
Synthesis of ester prodrugs of 9-(S)-[3-hydroxy-2-(phosphonomethoxy)propyl]-2,6-diaminopurine (HPMPDAP) as anti-poxvirus agentsMarcela Krecmerová, Antoín Holý, Graciela Andrei, et al.Bioorganic & Medicinal Chemistry|June 15, 2007
E,E,E-1-(4-Arylamino-4-oxo-2-butenoyl)-3,5-bis(arylidene)-4-piperidones: a topographical study of some novel potent cytotoxinsAmitabh Jha, Chandrani Mukherjee, Ashok K Prasad, et al.Medchemcomm|April 19, 2019
Potent antiviral activity of carbohydrate-specific algal and leguminous lectins from the Brazilian biodiversityAna C S Gondim, Suzete Roberta da Silva, Leen Mathys, et al.Journal of Medicinal Chemistry|December 4, 2015
Synthesis and Characterization of 4,11-Diaminoanthra[2,3-b]furan-5,10-diones: Tumor Cell Apoptosis through tNOX-Modulated NAD(+)/NADH Ratio and SIRT1Alexander S Tikhomirov, Andrey E Shchekotikhin, Yi-Hui Lee, et al.European Journal of Medicinal Chemistry|December 9, 2017
2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibitionRomeo Romagnoli, Maria Kimatrai Salvador, Santiago Schiaffino Ortega, et al.Journal of Medicinal Chemistry|June 28, 2002
Correlations between cytotoxicity and topography of some 2-arylidenebenzocycloalkanones determined by X-ray crystallographyJonathan R Dimmock, Gordon A Zello, Eliud O Oloo, et al.The Journal of Antimicrobial Chemotherapy|October 25, 2007
Preclinical development of bicyclic nucleoside analogues as potent and selective inhibitors of varicella zoster virusChristopher McGuigan, Ranjith N Pathirana, Marco Migliore, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|August 27, 2010
Different evolution of genotypic resistance profiles to emtricitabine versus lamivudine in tenofovir-containing regimensValentina Svicher, Claudia Alteri, Anna Artese, et al.Pageof 68